Fibrosis and Steatotic Liver Disease in US Adolescents According to the New Nomenclature
-
2024/08/01
Details
-
Personal Author:
-
Description:Objective: To apply the new nomenclature for steatotic liver diseases (SLD), replacing nonalcoholic fatty liver disease (NAFLD) with metabolic dysfunction-associated steatotic liver disease (MASLD), in adolescents using National Health and Nutrition Examination Survey (NHANES) data. Methods: Among 1410 adolescents (12-19 years) in NHANES (2017-March, 2020), the controlled attenuation parameter (CAP) of transient elastography (TE) was used to define steatosis and fibrosis (TE ≥ 7.4 kPa). Obesity and alanine aminotransferase (ALT) ≥ 80 U/L were used to identify adolescents qualifying for hepatology referral according to practice guidelines. NAFLD was defined as liver steatosis without a specific exposure; it has no cardiometabolic risk factor requirement, unlike MASLD. Results: Steatosis (yes/no) is the first decision point in the new diagnostic protocol; however, criteria for steatosis are undefined. At the supplier (EchoSens)-recommended CAP threshold of 240 dB/m, 30.5% (95% confidence interval [CI]: 27.1%-34.0%) of adolescents had SLD and about 85% of adolescents with NAFLD met criteria for MASLD. The other 15% would receive an ambiguous diagnosis of either cryptogenic SLD or possible MASLD. At higher CAP thresholds, MASLD/NAFLD concordance increased and approached 100%. Among adolescents with MASLD-fibrosis, only 8.8% (95% CI: 0%-19.3%) had overweight/obese and ALT ≥ 80 U/L. Conclusions: The new nomenclature highlights the high prevalence of liver steatosis. At the CAP threshold of 240 dB/m, however, approximately 15% of adolescents would receive an ambiguous diagnosis, which could lead to confusion and worry. Fewer than 10% of adolescents with MASLD-fibrosis had overweight/obese and ALT ≥ 80 U/L. Revised guidelines are needed to ensure that the other 90% receive appropriate referral and liver disease care. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0277-2116
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:229-237
-
Volume:79
-
Issue:2
-
NIOSHTIC Number:nn:20069663
-
Citation:J Pediatr Gastroenterol Nutr 2024 Aug; 79(2):229-237
-
Contact Point Address:Andrea D. Branch, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Pl, Box 1123, New York, NY 10029, USA
-
Email:andrea.branch@mssm.edu
-
Federal Fiscal Year:2024
-
Performing Organization:Icahn School of Medicine at Mount Sinai, New York
-
Peer Reviewed:True
-
Start Date:20170701
-
Source Full Name:Journal of Pediatric Gastroenterology and Nutrition
-
End Date:20240630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:f9867b252dec9cadc6934fe0f953d6a6cad016101f6a6989cc5ea7d35cdfcbd2efb1b3065a3340cfbc9996cfffa18c4816a8ddbb3162fb021f47f5cf83c0c953
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like